Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

NCT00317707 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12513

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases

Interventions

DRUG: N-3 Polyunsaturated Fatty Acids
DRUG: Placebo: Olive oil

Sponsor

Mario Negri Institute for Pharmacological Research